ArticleCancer medicine2016

Blood-based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance).

Ace J Hatch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.